AbbVie Inc Share | Buy US Stock from India on Kuvera

Q: Can I buy AbbVie Inc shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell AbbVie Inc stocks after a simple registration process. </div>

Q: How to buy AbbVie Inc shares in India?

<div> To buy AbbVie Inc shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for AbbVie Inc and you are done!</div> </div>

Q: What is the share price of AbbVie Inc?

<div>The share price of AbbVie Inc is USD 174.6 as on 18 Dec.</div>

Q: What is the Market Capitalization of AbbVie Inc?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of AbbVie Inc is USD 308.54B as on 18 Dec.</div>

Q: What is the PE ratio of AbbVie Inc?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of AbbVie Inc is 59.80 as on 18 Dec. </div>

Q: Is AbbVie Inc a good stock to buy?

<div>Kuvera provides relevant fundamental details of AbbVie Inc to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does AbbVie Inc operate?

<div> AbbVie Inc operates in Healthcare / Drug manufacturers - general

Healthcare Drug manufacturers - general

$174.6

-0.82

(18 Dec)

Loading Chart

Previous close

$174.60

Open

$174.60

Today’s high

$176.50

Today’s low

$173.93

52W low

$145.95

52W high

$207.32

13.77%

14.33%

59.80

Div yield

3.82%

EPS (TTM)

2.87

Shares O/S

1.77B

Market cap

308.54B

Insights

ABBV has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.

ABBV price is above its 200 day moving average

ABBV PE is in the top end of its range over the past 2 years

ABBV PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.

In beta. Send feedback here.

Compare with other stock

About AbbVie Inc

AbbVie Inc. is a diversified research-based biopharmaceutical company engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers a comprehensive product portfolio across Immunology, Oncology, Neuroscience, Eye Care, Aesthetics, and Other Specialties. Immunology includes Rheumatology, Dermatology, and Gastroenterology.

Oncology includes Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Diffuse large B-cell lymphoma, and others. Neuroscience includes Parkinson's disease, Migraine, Movement Disorders, Psychiatric Disorders, and Alzheimer’s disease. Eye Care includes Chronic Dry Eye Disease, Glaucoma, Age-Related Retinal Diseases, and Refractive Disorders. Aesthetics includes Botox Cosmetic, The Juvederm Collection of Fillers, and others. It offers NX-13 for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). It also offers CEL383 for the treatment of inflammatory bowel disease. .

FAQs

Can I buy AbbVie Inc shares in India?

How to buy AbbVie Inc shares in India?

What is the share price of AbbVie Inc?

What is the Market Capitalization of AbbVie Inc?

What is the PE ratio of AbbVie Inc?

Is AbbVie Inc a good stock to buy?

In which sector / industry does AbbVie Inc operate?